Showing results (31-40 of 87) with videos related to

Sort By:
Pageof 9
Journal of Virology|July 13, 2012
The NS1 protein of influenza A virus blocks RIG-I-mediated activation of the noncanonical NF-κB pathway and p52/RelB-dependent gene expression in lung epithelial cellsAndrea Rückle, Emanuel Haasbach, Ilkka Julkunen, et al.
Viral Immunology|June 23, 2010
The alternative NF-kappaB signalling pathway is a prerequisite for an appropriate immune response against lymphocytic choriomeningitis virus infectionKaroline Droebner, Bettina Klein, Stephan Paxian, et al.
Emerging Microbes & Infections|January 19, 2024
Identification and relative abundance of naturally presented and cross-reactive influenza A virus MHC class I-restricted T cell epitopesHazem Hamza, Michael Ghosh, Markus W Löffler, et al.
Frontiers in Immunology|December 28, 2020
NF-κB Pathway as a Potential Target for Treatment of Critical Stage COVID-19 PatientsRalf Kircheis, Emanuel Haasbach, Daniel Lueftenegger, et al.
Antiviral Research|July 11, 2018
The clinically approved MEK inhibitor Trametinib efficiently blocks influenza A virus propagation and cytokine expressionTobias Schräder, Sabine E Dudek, André Schreiber, et al.
Cellular Microbiology|August 3, 2006
Bivalent role of the phosphatidylinositol-3-kinase (PI3K) during influenza virus infection and host cell defenceChristina Ehrhardt, Henju Marjuki, Thorsten Wolff, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 24, 2010
Highly pathogenic influenza virus infection of the thymus interferes with T lymphocyte developmentAnnette B Vogel, Emanuel Haasbach, Sarah J Reiling, et al.
Antiviral Research|April 6, 2017
The MEK-inhibitor CI-1040 displays a broad anti-influenza virus activity in vitro and provides a prolonged treatment window compared to standard of care in vivoEmanuel Haasbach, Christin Müller, Christina Ehrhardt, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|February 11, 2011
Influenza virus H5N1 hemagglutinin (HA) T-cell epitope conjugates: design, synthesis and immunogenicityTheodore Skarlas, Stella Zevgiti, Karoline Droebner, et al.
Vaccine|January 4, 2011
Vaccine protection against lethal homologous and heterologous challenge using recombinant AAV vectors expressing codon-optimized genes from pandemic swine origin influenza virus (SOIV)Isaac Sipo, Mathias Knauf, Henry Fechner, et al.
Pageof 9